Search Results - M. Caskey

A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound by J. Lorenzi, Y. Cohen, L. Burke, M. Caskey, M. Nussenzweig

Connect to this object online.

PP 8.11 - 00174 Distinct HIV reservoir characteristics among individuals treated during primary versus chronic HIV infection by C. Bittar Oliva, A. Kaczynska, T. Oliveira, J. Frater, S. Fidler, M. Nussenzweig, M. Caskey, C. Gaebler

Connect to this object online.

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper by S. Fidler, S. Lewin, S. Deeks, O.S. Sogaard, L. Vandekerckhove, S. Collins, D. Kelly, J. Singh, M. Caskey, J. Frater

Connect to this object online.

OP 7.2 - 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: four cases from the open label arm of the RIO... by M. Lee, S. Collins, S. Kinloch, J. Fox, K. Seaton, G. Tomaras, M. Caskey, M. Nussenzweig, J. Frater, S. Fidle

Connect to this object online.

PP 3.12 - 00180 Distinct HIV-1 resistance profiles against bNAb in intact vs defective viral genomes by E.E. Giorgi, P. Khadka, E. Benko, C. Kovacs, R. Goswami, G.G. Fouda, S.R. Permar, M. Caskey, R. Brad Jones, G.Q. Lee

Connect to this object online.

Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA by N. Archin, K.J. Bar, T. Burdo, M. Caskey, A. Chahroudi, M. Farzan, Y.-C. Ho, R.B. Jones, Mary Kearney, D. Kuritzkes, D. Margolis, J. Martinez-Picado, A. Okoye, M. Salgado, Mario Stevenson

Connect to this object online.